Cargando…

Evaluation of Hematological Profile in Oral Submucous Fibrosis

Background: The aim of the study is to assess the hematological profile in oral submucous fibrosis (OSMF) patients. Methods: The study's participants (100) were divided into two groups. Group I consisted of fifty areca nut chewers with complaints of burning sensations, blanching, and stiffness...

Descripción completa

Detalles Bibliográficos
Autores principales: Abidullah, Mohammed, Gaddikeri, Kavitha, Anjum, Bushra, Vairagare, Swapneel, Tarani, Kulkarni, Seethamsetty, Swetcha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900455/
https://www.ncbi.nlm.nih.gov/pubmed/35265435
http://dx.doi.org/10.7759/cureus.21926
_version_ 1784664118178873344
author Abidullah, Mohammed
Gaddikeri, Kavitha
Anjum, Bushra
Vairagare, Swapneel
Tarani, Kulkarni
Seethamsetty, Swetcha
author_facet Abidullah, Mohammed
Gaddikeri, Kavitha
Anjum, Bushra
Vairagare, Swapneel
Tarani, Kulkarni
Seethamsetty, Swetcha
author_sort Abidullah, Mohammed
collection PubMed
description Background: The aim of the study is to assess the hematological profile in oral submucous fibrosis (OSMF) patients. Methods: The study's participants (100) were divided into two groups. Group I consisted of fifty areca nut chewers with complaints of burning sensations, blanching, and stiffness of the oral mucosa. Group II consisted of fifty healthy patients as controls. A hematological profile was estimated in all subjects. Results: The control group had a mean hemoglobin (Hb) of 13.87±1.26 g/dL, while the OSMF group had a mean Hb of 11.03±2.16 g/dL (P=0.001). The mean serum iron level in the control group was 120.36±41.22 g/dL, while it was 44.97±13.45 g/dL in the OSMF group (P=0.001). The control group's mean serum vitamin B12 values were 424.77±110.95 g/dL, while the OSMF group's was 210.11±44.88 g/dL (P=0.001). In the research population, 47 patients had iron deficiency. The odds ratio (OR) was 28.11, which meant that the high prevalence of iron deficiency was predicted 28.11 times more often than in the control group. Conclusion: As part of a biochemical assessment, iron status is assessed as part of a prevention mechanism for people who are at high risk. Biochemical testing has been suggested as a potential tool for mass screening OSMF patients.
format Online
Article
Text
id pubmed-8900455
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-89004552022-03-08 Evaluation of Hematological Profile in Oral Submucous Fibrosis Abidullah, Mohammed Gaddikeri, Kavitha Anjum, Bushra Vairagare, Swapneel Tarani, Kulkarni Seethamsetty, Swetcha Cureus Oral Medicine Background: The aim of the study is to assess the hematological profile in oral submucous fibrosis (OSMF) patients. Methods: The study's participants (100) were divided into two groups. Group I consisted of fifty areca nut chewers with complaints of burning sensations, blanching, and stiffness of the oral mucosa. Group II consisted of fifty healthy patients as controls. A hematological profile was estimated in all subjects. Results: The control group had a mean hemoglobin (Hb) of 13.87±1.26 g/dL, while the OSMF group had a mean Hb of 11.03±2.16 g/dL (P=0.001). The mean serum iron level in the control group was 120.36±41.22 g/dL, while it was 44.97±13.45 g/dL in the OSMF group (P=0.001). The control group's mean serum vitamin B12 values were 424.77±110.95 g/dL, while the OSMF group's was 210.11±44.88 g/dL (P=0.001). In the research population, 47 patients had iron deficiency. The odds ratio (OR) was 28.11, which meant that the high prevalence of iron deficiency was predicted 28.11 times more often than in the control group. Conclusion: As part of a biochemical assessment, iron status is assessed as part of a prevention mechanism for people who are at high risk. Biochemical testing has been suggested as a potential tool for mass screening OSMF patients. Cureus 2022-02-05 /pmc/articles/PMC8900455/ /pubmed/35265435 http://dx.doi.org/10.7759/cureus.21926 Text en Copyright © 2022, Abidullah et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Oral Medicine
Abidullah, Mohammed
Gaddikeri, Kavitha
Anjum, Bushra
Vairagare, Swapneel
Tarani, Kulkarni
Seethamsetty, Swetcha
Evaluation of Hematological Profile in Oral Submucous Fibrosis
title Evaluation of Hematological Profile in Oral Submucous Fibrosis
title_full Evaluation of Hematological Profile in Oral Submucous Fibrosis
title_fullStr Evaluation of Hematological Profile in Oral Submucous Fibrosis
title_full_unstemmed Evaluation of Hematological Profile in Oral Submucous Fibrosis
title_short Evaluation of Hematological Profile in Oral Submucous Fibrosis
title_sort evaluation of hematological profile in oral submucous fibrosis
topic Oral Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900455/
https://www.ncbi.nlm.nih.gov/pubmed/35265435
http://dx.doi.org/10.7759/cureus.21926
work_keys_str_mv AT abidullahmohammed evaluationofhematologicalprofileinoralsubmucousfibrosis
AT gaddikerikavitha evaluationofhematologicalprofileinoralsubmucousfibrosis
AT anjumbushra evaluationofhematologicalprofileinoralsubmucousfibrosis
AT vairagareswapneel evaluationofhematologicalprofileinoralsubmucousfibrosis
AT taranikulkarni evaluationofhematologicalprofileinoralsubmucousfibrosis
AT seethamsettyswetcha evaluationofhematologicalprofileinoralsubmucousfibrosis